ArticlePharmaceutics2026
An EGFR-Targeted Fusogenic Tandem Peptide for siRNA Delivery in Glioblastoma.
Jessica R Boulos, Karen E Russi, Jordan Kinnitt, Daphne Gomez Escudero, Tyler Willis, Jorrian Abadeer, Emalee Mann, Aaron Cristina Anderson, Angela Alexander-Bryant
Abstract read
In one paragraphArticle in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Jessica R BoulosDepartment of Bioengineering, Nanobiotechnology Laboratory, Clemson University, Clemson, SC 29631, USA.ORCID 0000-0003-3450-3266 Karen E RussiDepartment of Bioengineering, Nanobiotechnology Laboratory, Clemson University, Clemson, SC 29631, USA.
Jordan KinnittDepartment of Bioengineering, Nanobiotechnology Laboratory, Clemson University, Clemson, SC 29631, USA.
Daphne Gomez EscuderoDepartment of Bioengineering, Nanobiotechnology Laboratory, Clemson University, Clemson, SC 29631, USA.
Tyler WillisDepartment of Bioengineering, Nanobiotechnology Laboratory, Clemson University, Clemson, SC 29631, USA.ORCID 0009-0006-5360-0597 Jorrian AbadeerDepartment of Bioengineering, Nanobiotechnology Laboratory, Clemson University, Clemson, SC 29631, USA.
Emalee MannDepartment of Bioengineering, Nanobiotechnology Laboratory, Clemson University, Clemson, SC 29631, USA.
Aaron Cristina AndersonDepartment of Bioengineering, Nanobiotechnology Laboratory, Clemson University, Clemson, SC 29631, USA.
Angela Alexander-BryantDepartment of Bioengineering, Nanobiotechnology Laboratory, Clemson University, Clemson, SC 29631, USA.
Funding
Transnational Research Imaging Core (TRI)P30GM131959 · NIGMS · CLEMSON UNIVERSITY · PI VYAVAHARE, NAREN R · 2019 to 2023
$5.9MClemson Creative Inquiry N/AClemson University Honors College N/ACollege of Engineering, Computing, and Applied Sciences' Undergraduate Opportunity Research Grant program N/ANational Science Foundation OIA-1655740NIGMS NIH HHS P30 GM131959NIGMS NIH HHS P30GM131959
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
glioblastomapeptide-based delivery systemRNA interferencesiRNAtargeted gene therapy
Identifiers
PMID42797260
PMCPMC13610838
What OpenQuestion holds
Textmetadata
Read underepoch 390